Differential prognostic impact of CD8 T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer.

08:00 EDT 17th March 2020 | BioPortfolio

Summary of "Differential prognostic impact of CD8 T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer."

The aim of the study was to determine the human leucocyte antigen class-I (HLA-I), programmed death-ligand 1 (PD-L1) expression and tumour-infiltrating lymphocytes (TILs) of microsatellite instability-high gastric cancer.


Journal Details

This article was published in the following journal.

Name: British journal of cancer
ISSN: 1532-1827


DeepDyve research library

PubMed Articles [46772 Associated PubMed Articles listed on BioPortfolio]

Extracellular vesicles in human semen modulate antigen-presenting cell function and decrease downstream antiviral T cell responses.

Human semen contains trillions of extracellular vesicles (SEV) similar in size to sexually transmitted viruses and loaded with potentially bioactive miRNAs, proteins and lipids. SEV were shown to inhi...

HLA expression levels of unstimulated and cytokine stimulated human umbilical vein endothelial cells.

Transplant rejection occurs following recipient recognition of mismatched human leucocyte antigen (HLA) on donor tissue, but active rejection is dependent not only upon the severity of the T cell or a...

Triple (GGTA1, CMAH, B2M) modified pigs expressing an SLA class-I phenotype - effects on immune status and susceptibility to human immune responses.

Porcine xenografts lacking SLA (swine leucocyte antigen) class-I are thought to be protected from human T cell responses. We have previously shown that SLA class-I deficiency can be achieved in pigs b...

Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity.

The structure of the human leucocyte antigen (HLA) peptide-binding clefts strongly contributes to monoglandular and polyglandular autoimmunity (AP).

HLA-B27 alters BMP/TGFβ signalling in , revealing putative pathogenic mechanism for spondyloarthritis.

The human leucocyte antigen (HLA)-B27 confers an increased risk of spondyloarthritis (SpA) by unknown mechanism. The objective of this work was to uncover HLA-B27 non-canonical properties that could e...

Clinical Trials [21147 Associated Clinical Trials listed on BioPortfolio]

Human Leucocyte Antigen G and Chronic Heart Failure

The Human leukocyte antigen G (HLA-G) is a non-classical, major histocompatibility complex class I (MHC-I) protein that modulates the immune response, inhibiting it in most cases. Physiolo...

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

This project will involve a systematic literature review and meta-analysis of studies assessing the impact of complement-activating anti-Human Leukocyte Antigen (HLA) donor specific antibo...

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Minimal-residual disease (MRD) will be measured either by flow cytometry, or polymerase chain reaction (PCR) methods, in 3 check-points and it will be one of the decision-making control pa...

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis Type II or Schwannomatosis

The primary objective of this study is to verify the safety of antigen-specific T cells (CAR-T) and engineered immune effector cytotoxic T cells (EIE) modified by immunoregulatory genes an...

Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)

Chemotherapy is the current standard treatment for unresectable recurrent cervical carcinoma after radiotherapy or distant metastasis of cervical carcinoma. The most effective regimens are...

Medical and Biotech [MESH] Definitions

Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.

Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells.

Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is associated with RHEUMATOID ARTHRITIS and SCHIZOPHRENIA.

Non-hematopoietic cells, with extensive dendritic processes, found in the primary and secondary follicles of lymphoid tissue (the B cell zones). They are different from conventional DENDRITIC CELLS associated with T-CELLS. They are derived from MESENCHYMAL STEM CELLS and are negative for class II MHC antigen and do not process or present antigen like the conventional dendritic cells do. Instead, follicular dendritic cells have FC RECEPTORS and C3B RECEPTORS that hold antigen in the form of ANTIGEN-ANTIBODY COMPLEXES on their surfaces for long periods for recognition by B-CELLS.

A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.

Quick Search

DeepDyve research library

Relevant Topic

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Searches Linking to this Article